CHS - Community Health Systems Inc. reported Q4 FY2025 net operating revenues of USD 3.11 billion (-4.9%) and Adjusted EBITDA of USD 395.00 million. Net income attributable to stockholders was USD 110.00 million (USD 0.81 diluted EPS), versus a net loss in Q4 FY2024; excluding adjusting items, diluted EPS was no income per share, versus a loss per share in the prior-year quarter. Net cash provided by operating activities was USD 266.00 million in Q4 FY2025. For FY2025, CHS - Community Health Systems Inc. posted net operating revenues of USD 12.49 billion (-1.2%), Adjusted EBITDA of USD 1.53 billion, and net income attributable to stockholders of USD 509.00 million (USD 3.77 diluted EPS); excluding adjusting items, diluted EPS was USD 1.19. FY2025 net cash provided by operating activities was USD 543.00 million. In corporate updates, the company redeemed USD 223.00 million of its 10.875% Senior Secured Notes due 2032 and repaid the remaining USD 14.00 million of 5.625% Senior Secured Notes due 2027 during Q4, and redeemed another USD 223.00 million of the 2032 notes on Feb. 2, 2026. CHS - Community Health Systems Inc. also highlighted 2025 hospital divestitures and the Dec. 1, 2025 sale of select ambulatory outreach lab assets across 13 states to Laboratory Corporation of America Holdings for USD 194.00 million (before transaction expenses), as well as the Feb. 1, 2026 completion of agreed sales to Tenor Health Foundation affiliates and to Vanderbilt University Medical Center subsidiaries (USD 623.00 million cash proceeds, subject to adjustments). CEO Kevin J. Hammons said results were consistent with expectations and the company entered 2026 with “solid momentum and an improved financial position.”
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CHS - Community Health Systems Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260218019081) on February 18, 2026, and is solely responsible for the information contained therein.